EdgarLookup

United States Natural Gas Fund, LP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that United States Natural Gas Fund, LP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
68.9%
Profit Margin
Net income ÷ revenue
0.6%
Return on Assets
Net income ÷ assets
+109.9%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.37M Feb 27, 2026
FY2025 Sep 30, 2025 ($54.50M) Feb 27, 2026
FY2025 Jun 30, 2025 ($121.29M) Feb 27, 2026
FY2025 Mar 31, 2025 $210.75M Feb 27, 2026
FY2025 Dec 31, 2024 $56.24M Feb 27, 2026
FY2025 Sep 30, 2024 $4.45M Feb 27, 2026
FY2025 Jun 30, 2024 $176.59M Feb 27, 2026
FY2025 Mar 31, 2024 ($162.01M) Feb 27, 2026
FY2024 Dec 31, 2023 ($251.23M) Feb 28, 2025
FY2024 Sep 30, 2023 ($78.99M) Feb 28, 2025

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.70M Feb 27, 2026
FY2025 Sep 30, 2025 ($55.88M) Feb 27, 2026
FY2025 Jun 30, 2025 ($122.42M) Feb 27, 2026
FY2025 Mar 31, 2025 $208.82M Feb 27, 2026
FY2025 Dec 31, 2024 $53.73M Feb 27, 2026
FY2025 Sep 30, 2024 $1.91M Feb 27, 2026
FY2025 Jun 30, 2024 $174.08M Feb 27, 2026
FY2025 Mar 31, 2024 ($164.57M) Feb 27, 2026
FY2024 Dec 31, 2023 ($253.71M) Feb 28, 2025
FY2024 Sep 30, 2023 ($81.64M) Feb 28, 2025

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $127.15M Feb 27, 2026
FY2025 Dec 31, 2024 $47.54M Feb 27, 2026
FY2025 Dec 31, 2023 ($865.00M) Feb 27, 2026
FY2024 Dec 31, 2022 $215.54M Feb 28, 2025
FY2023 Dec 31, 2021 $7.18M Feb 29, 2024
FY2022 Dec 31, 2020 ($208.65M) Feb 27, 2023
FY2021 Dec 31, 2019 ($124.37M) Feb 25, 2022
FY2020 Dec 31, 2018 $232.59M Feb 26, 2021
FY2019 Dec 31, 2017 ($256.04M) Mar 13, 2020
FY2018 Dec 31, 2016 $166.37M Mar 13, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $579.49M Feb 27, 2026
FY2025 Dec 31, 2024 $790.02M Feb 27, 2026
FY2024 Dec 31, 2023 $987.76M Feb 28, 2025
FY2023 Dec 31, 2022 $430.68M Feb 29, 2024
FY2022 Dec 31, 2021 $377.06M Feb 27, 2023
FY2021 Dec 31, 2020 $426.16M Feb 25, 2022
FY2020 Dec 31, 2019 $445.62M Feb 26, 2021
FY2019 Dec 31, 2018 $292.94M Mar 13, 2020
FY2018 Dec 31, 2017 $707.85M Mar 13, 2019
FY2017 Dec 31, 2016 $610.07M Feb 28, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $28.85M Feb 27, 2026
FY2025 Dec 31, 2024 $46.19M Feb 27, 2026
FY2024 Dec 31, 2023 $13.90M Feb 28, 2025
FY2023 Dec 31, 2022 $1.34M Feb 29, 2024
FY2022 Dec 31, 2021 $5.52M Feb 27, 2023
FY2021 Dec 31, 2020 $11.56M Feb 25, 2022
FY2020 Dec 31, 2019 $1.04M Feb 26, 2021
FY2019 Dec 31, 2018 $44.93M Mar 13, 2020
FY2018 Dec 31, 2017 $55.76M Mar 13, 2019
FY2017 Dec 31, 2016 $72.26M Feb 28, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $438.46M Feb 27, 2026
FY2025 Dec 31, 2024 $593.54M Feb 27, 2026
FY2025 Dec 31, 2023 $678.02M Feb 27, 2026
FY2024 Dec 31, 2022 $317.87M Feb 28, 2025
FY2023 Dec 31, 2021 $248.40M Feb 29, 2024
FY2022 Dec 31, 2020 $342.94M Feb 27, 2023
FY2021 Dec 31, 2019 $375.59M Feb 25, 2022
FY2020 Dec 31, 2018 $259.49M Feb 26, 2021
FY2019 Dec 31, 2017 $550.94M Mar 13, 2020
FY2018 Dec 31, 2016 $522.82M Mar 13, 2019